早期子宫乳头状浆液性癌放射治疗的应用价值
研究利用美国国家癌症数据库分析1998至2012年7325例I-II期子宫乳头状浆液性癌患者,发现化疗与死亡率降低22%相关(HR=0.78),阴道近距离放疗与死亡率降低相关(HR=0.67),而体外放疗与生存无关(HR=1.03)。
要点
- 化疗与早期UPSC患者死亡率降低22%相关(HR=0.78;95%CI 0.69-0.88)。
- 阴道近距离放疗与死亡率降低相关(HR=0.67;95%CI 0.57-0.78),体外放疗与生存无关(HR=1.03;95%CI 0.92-1.17)。
- 化疗与IB期和II期死亡率降低相关,但与IA期无关;阴道近距离放疗与IA期和II期死亡率降低相关。
核心结论
- 对于早期子宫乳头状浆液性癌女性,化疗与生存改善相关;阴道近距离放疗亦与生存改善相关,但体外放疗获益甚微。
研究设计与样本
- 利用美国国家癌症数据库识别1998年至2012年间治疗的I-II期子宫乳头状浆液性癌女性,共7325例。
- 分析化疗、近距离放疗和体外放疗的使用趋势,并采用多变量Cox比例风险模型检验这些治疗与死亡率的相关性。
主要发现
- 共有7325例患者被识别,其中2779例(37.9%)接受了化疗。
- 阴道近距离放疗使用率从1998年的7.2%上升至2012年的29.1%(P<0.0001),同期体外放疗使用率从18.2%下降至11.7%(P<0.0001)。
- 化疗与死亡率降低22%相关(HR=0.78;95%CI 0.69-0.88)。
- 阴道近距离放疗与死亡率降低相关(HR=0.67;95%CI 0.57-0.78),而体外放疗与生存无关(HR=1.03;95%CI 0.92-1.17)。
- 按分期分层,化疗与IB期和II期肿瘤患者死亡率降低相关,但与IA期肿瘤无关;阴道近距离放疗与IA期和II期肿瘤死亡率降低相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Early-stage uterine papillary serous carcinoma (UPSC) has a poor prognosis and high recurrence rate. While adjuvant chemotherapy is generally recommended, the role of radiation is uncertain. We examined the association between vaginal brachytherapy and whole pelvic radiation and survival in women treated with and without adjuvant chemotherapy. METHODS: The National Cancer Data Base was used to identify women with stage I-II UPSC treated between 1998 and 2012. Trends in use of chemotherapy, brachytherapy, and external beam radiation over time were examined. The association between these treatments and mortality were examined using multivariable Cox proportional hazards models. RESULTS: A total of 7325 patients were identified. Overall, 2779 (37.9%) received chemotherapy. The use of vaginal brachytherapy increased from 7.2% in 1998 to 29.1% in 2012 (P<0.0001), while use of external beam radiation decreased from 18.2% to 11.7% over the same period (P<0.0001). Use of chemotherapy was associated with a 22% reduction in mortality (HR=0.78; 95% CI, 0.69-0.88). While brachytherapy was associated with decreased mortality (HR=0.67; 95% CI, 0.57-0.78), use of external beam radiation was not associated with survival (HR=1.03; 95% CI, 0.92-1.17). Stratified by stage, use of chemotherapy was associated with decreased mortality for women with stage IB and II tumors, but not for stage IA neoplasms. Vaginal brachytherapy was associated with reduced mortality for stage IA and II neoplasms. CONCLUSION: For women with early-stage UPSC, chemotherapy is associated with improved survival. Vaginal brachytherapy was also associated with improved survival, however, there was little benefit to use of external beam radiation.
引用
- Cham S, Huang Y, Tergas AI, et al. Utility of radiation therapy for early-stage uterine papillary serous carcinoma. Gynecol Oncol. 2017. PMID: 28343693. doi:10.1016/j.ygyno.2017.03.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。